Postoperatif pnömonide antibiyotik tedavisi

Pnömoni büyük cerrahi veya yaralanmalardan sonra sık görülen bir komplikasyondur. Cerrahi girişim yapılan hastalarda pnömoni ile ilişkili mortalite hızı % 10-18 arasındadır. Doğru antibiyotik tedavisi postoperatif pnömonili hastalarda surviyi önemli oranda iyileştirmektedir. Çalışmalar, uygun olmayan antibiyotiklerle tedaviye başlanan hastalarda mortalite oranlarının yüksek olduğunu gösterdiğinden başlangıçta seçilecek en uygun ampirik antibiyotik tedavisi çok önemlidir. Çoğunlukla tedavi, kültür sonuçları beklenmeden başlanmalı ve gerekirse sonradan modifiye edilmelidir. *25.ANKEM Antibiyotik ve Kemoterapi Kongresi, Yatay İnteraktif Kurs 1C sunularından (28 Nisan-02 Mayıs 2010, Kuzey Kıbrıs Türk Cumhuriyeti)

Antibiotic treatment in postoperative pneumonia

Pneumonia is a frequent complication after major surgery or injury. Mortality associated with pneumonia in surgical patients ranges from 10 % to 18 %. Appropriate antibiotic therapy significantly improves survival for patients with postoperative pneumonia. The empirical choice of the most appropriate antibiotic agent at the outset is crucial, because studies showed a higher mortality rate in patients treated initially with an inappropriate antibiotic. Commonly, treatment has to be started without waiting for culture results and, if necessary, should be subsequently modified depending on the later.

PDF

___

1. American Thoracic Society: Guidelines for the management of adult with hospital acquired, ventilator-associated and healthcare-associated pneumonia, Am J Respir Crit Care Med 2005; 171(4):388-416.
2. Chastre J: Antimicrobial treatment of hospital-acquired pneumonia, Infect Dis Clin North Am 2003;17(4):727-37.
3. Chastre J, Wolff M, Fagon J et al: Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults, JAMA 2003; 290(19):2588-98.
4. Celis R, Torres A, Gatell J et al: Nosocomial pneumonia: a multivariate analysis of risk and prognosis, Chest 1988;93(2):318-24.
5. Combes A, Luyt C, Fagon J et al: Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia, Crit Care Med 2007;35(1):146-54.
6. Croce MA, Fabian TC, Stewart RM et al: Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients, J Trauma 1993;35(2):303-9.
7. Dupont H, Montravers P, Gauzit R, Veber B, Pouriat JL, Martin C, Club d’Infectiologie en Anesthesie-Reanimation: Outcome of postoperative pneumonia in the Eole study, Intensive Care Med 2003;29(2):179-88.
8. Falagas ME, Kasiakou SK: Colistin the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections, Clin Infect Dis 2005;40(9):1333-41.
9. Fisher BW, Majumdar SR, McAlister FA: Predicting pulmonary complications after nonthoracic surgery: a systematic review of blinded studies, Am J Med 2002;112(3):219-25.
10. French GL: Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin, J Antimicrob Chemother 2006;58(3):1107-17.
11. Garcia JCP, Filho OFF, Grion CMC et al: Impact of the implementation of a therapeutic guideline on the treatment of nosocomial pneumonia acquired in the intensive care unit of a university hospital, J Bras Pneumol 2007;33(2):175-84.
12. Garnacho-Montero, J, Sa-Borges, M, Sole-Violan J et al: Optimal management therapy for Pseudo-monas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy, Crit Care Med 2007;35(8):1888-95.
13. Giantsou E, Liratzopoulos N, Efraimidou E et al: De-escalation therapy rates are significantly higher by bronchalveolar lavage than by tracheal aspiration, Intensive Care Med 2007;33(9):1533-40.
14. Heyland DK, Dodek P, Muscedere J et al: Randomized trial of combination versus mono-therapy for the empiric treatment of suspected ventilator-associated pneumonia, Crit Care Med 2008;36(3):737-44.
15. Kieninger AN, Lipsett PA: Hospital-acquired pneumonia: pathophysiology, diagnosis, and treatment, Surg Clin North Am 2009;89(2):439-61.
16. Lawrence VA, Hilsenbeck S, Mulrow C, Ohanda R, Sapp J, Page CP: Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery, J Gen Intern Med 1995;10(12): 671-8.
17. Linden PK, Paterson DL: Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia, Clin Infect Dis 2006;43(Suppl 2):89-94.
18. Lynch JP: Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit, Semin Respir Infect 1993;8(4):268-84.
19. Mandell LA, Wunderink RG, Anzueto A et al: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults, Clin Infect Dis 2007;44(Suppl 2):S27-72.
20. Maragakis LL, Perl TM: Acinetobacter baumannii: epidemiology, antimicrobial resistance and treatment options, Clin Infect Dis 2008;46(8):1254-63.
21. McAlister FA, Khan NA, Straus SE et al: Accuracy of the preoperative assessment in predicting pulmonary risk after nonthoracic surgery, Am J Respir Crit Care Med 2003;167(5):741-74.
22. Michalopoulos A, Fotakis D, Virtzili S et al: Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant gram negative bacteria: a prospective study, Respir Med 2008;102(3):407-12.
23. Montravers P, Veber B, Auboyer C et al: Diagnostic and therapeutic management of nosocomial pneu-monia in surgical patients: results of the Eole study, Crit Care Med 2002;30(2):368-75.
24. Park DR: The microbiology of ventilator-associated pneumonia, Respir Care 2005;50(6):742-65.
25. Raad I, Hachem R, Hanna H et al: Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study, Ann Surg Oncol 2001;8(2):179-86.
26. Rello J, Vidaur L, Sandiumenge A et al: De-escalation therapy in ventilator-associated pneumonia, Crit Care Med 2004;32(11):2183-90.
27. Rios FG, Luna CM, Maskin B et al: Ventilator-associated pneumonia due to colistin susceptible-only microorganisms, Eur Respir J 2007;30(2)307-13.
28. Schein M: Postoperative pneumonia, Current Surgery 2002;59(6):540-8.
29. Shorr AF, Combes A, Kollef MH et al: Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy, Crit Care Med 2006;34(3):700-6.
30. Singh N, Falestiny MN, Rogers P et al: Pulmonary infiltrates in the surgical ICU: prospective assessment of predictors of etiology and mortality, Chest 1998;114(4):1129-36.
31. Smetana GW, Lawrence VA, Cornell JE: Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians, Ann Intern Med 2006;144(8):581-95.
32. Torres A, Ewig S, Lode H, Carlet J, European HAP Working Group: Defining, treating and preventing hospital acquired pneumonia: European perspective, Intensive Care Med 2009;35(1):9-29.
33. Türk Toraks Derneği: Erişkinlerde Toplumda Gelişen Pnömoni Tanı ve Tedavi Uzlaşı Raporu, Türk Toraks Derg 2009;10(Suppl 9):1-12.
34. Wang G, Hindler JF, Ward KW et al: Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period, J Clin Microbiol 2006;44(11):3883-6.
35. von Dossow V, Rotard K, Redlich U et al: Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients, Crit Care 2005;9(6):R662-9.
36. Zilberberg MD, Shorr AF, Micek ST et al: Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience, Chest 2008;134(5):963-8.